kras mutation and glutathion glynac Oncogenic Kras Maintains Pancreatic Tumors
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Metabolic reprogramming in KRAS mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies ScienceDirect KRAS: feeding pancreatic cancer proliferation: Trends in Biochemical Sciences Pancreatic Cancer: Advances and Challenges PMC
Pay in 4 interest-free payments of $6.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



